Cargando…

Wang D, Sun Z, Zhu X, et al. GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT. Blood. 2022;140(26):2788-2804.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273081/
https://www.ncbi.nlm.nih.gov/pubmed/37052937
http://dx.doi.org/10.1182/blood.2023020134
_version_ 1785059629324042240
collection PubMed
description
format Online
Article
Text
id pubmed-10273081
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-102730812023-06-17 Wang D, Sun Z, Zhu X, et al. GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT. Blood. 2022;140(26):2788-2804. Blood Erratum The American Society of Hematology 2023-04-13 2023-04-13 /pmc/articles/PMC10273081/ /pubmed/37052937 http://dx.doi.org/10.1182/blood.2023020134 Text en © 2023 by The American Society of Hematology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Erratum
Wang D, Sun Z, Zhu X, et al. GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT. Blood. 2022;140(26):2788-2804.
title Wang D, Sun Z, Zhu X, et al. GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT. Blood. 2022;140(26):2788-2804.
title_full Wang D, Sun Z, Zhu X, et al. GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT. Blood. 2022;140(26):2788-2804.
title_fullStr Wang D, Sun Z, Zhu X, et al. GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT. Blood. 2022;140(26):2788-2804.
title_full_unstemmed Wang D, Sun Z, Zhu X, et al. GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT. Blood. 2022;140(26):2788-2804.
title_short Wang D, Sun Z, Zhu X, et al. GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT. Blood. 2022;140(26):2788-2804.
title_sort wang d, sun z, zhu x, et al. garp-mediated active tgf-β1 induces bone marrow nk cell dysfunction in aml patients with early relapse post–allo-hsct. blood. 2022;140(26):2788-2804.
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273081/
https://www.ncbi.nlm.nih.gov/pubmed/37052937
http://dx.doi.org/10.1182/blood.2023020134